You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 5, February 7, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy

Carl M. Mendel, MD; Robert F. Klein, MD; David A. Chappell, MD; Willard H. Dere, MD; Barry J. Gertz, MD, PhD; John H. Karam, MD; Thomas N. Lavin, MD; Carl Grunfeld, MD, PhD

JAMA. 1986;255(5):637-639.


Abstract

We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a graphic rating scale. A placebo response was found, but no additional effect of amitriptyline and fluphenazine was seen. Although the statistical power of this study was low, these data, when combined with a reevaluation of previous trials of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, indicate that there is no justification for the use of these agents in the treatment of painful neuropathy outside of large, controlled clinical trials. Depression as a possible cause of this condition should not go unnoted or untreated.

(JAMA 1986;255:637-639)



Author Affiliations

From the Division of Endocrinology, Department of Medicine, University of California, San Francisco (Drs Mendel, Klein, Chappell, Dere, Gertz, Karam, Lavin, and Grunfeld); and the Metabolism Section, Medical Service, San Francisco Veterans Administration Medical Center (Dr Grunfeld).


Footnotes

Reprint requests to Metabolism Section (111F), San Francisco Veterans Administration Medical Center, 4150 Clement St, San Francisco, CA 94121 (Dr Grunfeld).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depression and Diabetic Neuropathy: A Complex Relationship
Geringer et al.
J Geriatr Psychiatry Neurol 1988;1:11-15.
ABSTRACT  

Diabetic Peripheral Neuropathies
HARATI
ANN INTERN MED 1987;107:546-559.
ABSTRACT  

Review Article: Psychopharmacologic Treatment in Neurological Practice
Dubovsky and Ringel
Neurorehabil Neural Repair 1987;1:51-66.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.